163 related articles for article (PubMed ID: 16253234)
1. Novel pharmacotherapeutic targets for the management of drug addiction.
Heidbreder C
Eur J Pharmacol; 2005 Dec; 526(1-3):101-12. PubMed ID: 16253234
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving.
Heidbreder CA; Hagan JJ
Curr Opin Pharmacol; 2005 Feb; 5(1):107-18. PubMed ID: 15661634
[TBL] [Abstract][Full Text] [Related]
4. New achievements and pharmacotherapeutic approaches in the treatment of alcohol dependence.
Kiefer F; Mann K
Eur J Pharmacol; 2005 Dec; 526(1-3):163-71. PubMed ID: 16266700
[TBL] [Abstract][Full Text] [Related]
5. Psychopharmacological treatment of aggression and violence in the substance using population.
Lavine R
J Psychoactive Drugs; 1997; 29(4):321-9. PubMed ID: 9460025
[TBL] [Abstract][Full Text] [Related]
6. [Addicted patients: do not distribute street drugs: do treat with registered psychoactive medication].
De Jong CA
Ned Tijdschr Geneeskd; 2007 Sep; 151(36):1970-2. PubMed ID: 17953168
[TBL] [Abstract][Full Text] [Related]
7. 1990-1991 survey of pharmacotherapies used in the treatment of cocaine abuse.
Halikas JA; Nugent SM; Crosby RD; Carlson GA
J Addict Dis; 1993; 12(2):129-39. PubMed ID: 8476938
[TBL] [Abstract][Full Text] [Related]
8. Advances in psychotropic formulations.
Keith S
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):996-1008. PubMed ID: 16678954
[TBL] [Abstract][Full Text] [Related]
9. [Psychotropic drugs in the management of alcoholism and drug addiction?].
Athen D
MMW Munch Med Wochenschr; 1982 Feb; 124(7):137-8. PubMed ID: 6801490
[No Abstract] [Full Text] [Related]
10. Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder.
Brunette MF; Mueser KT
J Clin Psychiatry; 2006; 67 Suppl 7():10-7. PubMed ID: 16961419
[TBL] [Abstract][Full Text] [Related]
11. Overview of pharmacologic treatment approaches for alcohol and other drug addiction. Intoxication, withdrawal, and relapse prevention.
Gorelick DA
Psychiatr Clin North Am; 1993 Mar; 16(1):141-56. PubMed ID: 8456040
[TBL] [Abstract][Full Text] [Related]
12. Novel pharmacological approaches to drug abuse treatment.
Edens E; Massa A; Petrakis I
Curr Top Behav Neurosci; 2010; 3():343-86. PubMed ID: 21161760
[TBL] [Abstract][Full Text] [Related]
13. Challenges in genetic studies of the etiology of substance use and substance use disorders: introduction to the special issue.
Prescott CA; Madden PA; Stallings MC
Behav Genet; 2006 Jul; 36(4):473-82. PubMed ID: 16710779
[TBL] [Abstract][Full Text] [Related]
14. Stages of change for psychotropic medication adherence and substance cessation.
Finnell DS; Osborne FH
Arch Psychiatr Nurs; 2006 Aug; 20(4):166-74. PubMed ID: 16846777
[TBL] [Abstract][Full Text] [Related]
15. [Relapse prevention in drug addicts].
Rácz J
Neuropsychopharmacol Hung; 2013 Dec; 15(4):232-8. PubMed ID: 24380964
[TBL] [Abstract][Full Text] [Related]
16. Psychoactive drug abuse in older adults.
Simoni-Wastila L; Yang HK
Am J Geriatr Pharmacother; 2006 Dec; 4(4):380-94. PubMed ID: 17296542
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.
Potvin S; Stip E; Lipp O; Elie R; Mancini-Marië A; Demers MF; Roy MA; Bouchard RH; Gendron A
Curr Med Res Opin; 2006 Jul; 22(7):1277-85. PubMed ID: 16834826
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy for addictions: partnering with contingency management.
Kosten TR
Am J Drug Alcohol Abuse; 2007; 33(3):341-2. PubMed ID: 17613962
[No Abstract] [Full Text] [Related]
19. Use and abuse of psychoactive drugs in the elderly.
Morrant JC
Can Med Assoc J; 1983 Aug; 129(3):245-8. PubMed ID: 6861062
[TBL] [Abstract][Full Text] [Related]
20. Abstinence-Conflict Model: Toward an Optimal Animal Model for Screening Medications Promoting Drug Abstinence.
Peck JA
Int Rev Neurobiol; 2016; 126():391-402. PubMed ID: 27055619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
